151 related articles for article (PubMed ID: 33607326)
1. Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of
Fiaccabrino DE; Kunz P; Radchenko V
Nucl Med Biol; 2021; 94-95():81-91. PubMed ID: 33607326
[TBL] [Abstract][Full Text] [Related]
2. Development of implantation substrates for the collection of radionuclides of medical interest produced via ISOL technique at INFN-LNL.
Ballan M; Vettorato E; Morselli L; Tosato M; Nardella S; Borgna F; Corradetti S; Monetti A; Lunardon M; Zenoni A; Di Marco V; Realdon N; Andrighetto A
Appl Radiat Isot; 2021 Sep; 175():109795. PubMed ID: 34087532
[TBL] [Abstract][Full Text] [Related]
3. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.
Randhawa P; Olson AP; Chen S; Gower-Fry KL; Hoehr C; Engle JW; Ramogida CF; Radchenko V
Curr Radiopharm; 2021; 14(4):394-419. PubMed ID: 33430758
[TBL] [Abstract][Full Text] [Related]
4. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of MC1R targeting theranostic pair [
Wharton L; McNeil SW; Zhang C; Engudar G; Van de Voorde M; Zeisler J; Koniar H; Sekar S; Yuan Z; Schaffer P; Radchenko V; Ooms M; Kunz P; Bénard F; Yang H
Nucl Med Biol; 2024 May; 136-137():108925. PubMed ID: 38796924
[TBL] [Abstract][Full Text] [Related]
6. A preliminary study for the production of high specific activity radionuclides for nuclear medicine obtained with the isotope separation on line technique.
Borgna F; Ballan M; Corradetti S; Vettorato E; Monetti A; Rossignoli M; Manzolaro M; Scarpa D; Mazzi U; Realdon N; Andrighetto A
Appl Radiat Isot; 2017 Sep; 127():214-226. PubMed ID: 28649019
[TBL] [Abstract][Full Text] [Related]
7. Cyclotron Production and Separation of Scandium Radionuclides from Natural Titanium Metal and Titanium Dioxide Targets.
Loveless CS; Blanco JR; Diehl GL; Elbahrawi RT; Carzaniga TS; Braccini S; Lapi SE
J Nucl Med; 2021 Jan; 62(1):131-136. PubMed ID: 32620699
[TBL] [Abstract][Full Text] [Related]
8. Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with
Kostelnik TI; Olson AP; Grundmane A; Ellison PA; Mynerich J; Chen S; Marinova A; Randhawa P; Karaivanov D; Aluicio-Sarduy E; Barnhart TE; Orvig C; Ramogida CF; Hoehr C; Filosofov D; Engle JW; Radchenko V
Nucl Med Biol; 2023; 122-123():108352. PubMed ID: 37390607
[TBL] [Abstract][Full Text] [Related]
9. The production of radionuclides for nuclear medicine from a compact, low-energy accelerator system.
Webster WD; Parks GT; Titov D; Beasley P
Nucl Med Biol; 2014 May; 41 Suppl():e7-15. PubMed ID: 24434013
[TBL] [Abstract][Full Text] [Related]
10. Production of Copper Radionuclides in Compact Medical Cyclotrons using Solid Targets.
Avila-Rodriguez MA; Valdovinos HF
Curr Radiopharm; 2021; 14(4):340-353. PubMed ID: 32981514
[TBL] [Abstract][Full Text] [Related]
11. Recent great impact by an Isotope Separator On-Line (ISOL) in nuclear and radiochemistry.
Sakama M
J Med Invest; 2016; 63(1-2):19-26. PubMed ID: 27040048
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced
Ramogida CF; Robertson AKH; Jermilova U; Zhang C; Yang H; Kunz P; Lassen J; Bratanovic I; Brown V; Southcott L; Rodríguez-Rodríguez C; Radchenko V; Bénard F; Orvig C; Schaffer P
EJNMMI Radiopharm Chem; 2019 Aug; 4(1):21. PubMed ID: 31659557
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Radiometals Beyond
Müller C; van der Meulen NP; Benešová M; Schibli R
J Nucl Med; 2017 Sep; 58(Suppl 2):91S-96S. PubMed ID: 28864619
[TBL] [Abstract][Full Text] [Related]
14. Early Evaluation of Copper Radioisotope Production at ISOLPHARM.
Borgna F; Ballan M; Favaretto C; Verona M; Tosato M; Caeran M; Corradetti S; Andrighetto A; Di Marco V; Marzaro G; Realdon N
Molecules; 2018 Sep; 23(10):. PubMed ID: 30249975
[TBL] [Abstract][Full Text] [Related]
15. The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy.
Lehenberger S; Barkhausen C; Cohrs S; Fischer E; Grünberg J; Hohn A; Köster U; Schibli R; Türler A; Zhernosekov K
Nucl Med Biol; 2011 Aug; 38(6):917-24. PubMed ID: 21843788
[TBL] [Abstract][Full Text] [Related]
16. Nuclear data for production and medical application of radionuclides: Present status and future needs.
Qaim SM
Nucl Med Biol; 2017 Jan; 44():31-49. PubMed ID: 27821344
[TBL] [Abstract][Full Text] [Related]
17. Production of medical radionuclides in Russia: status and future--a review.
Zhuikov BL
Appl Radiat Isot; 2014 Feb; 84():48-56. PubMed ID: 24315977
[TBL] [Abstract][Full Text] [Related]
18. An alternate approach to the production of radioisotopes for nuclear medicine applications.
D'Auria JM; Keller R; Ladouceur K; Lapi SE; Ruth TJ; Schmor P
Rev Sci Instrum; 2013 Mar; 84(3):034705. PubMed ID: 23556835
[TBL] [Abstract][Full Text] [Related]
19. Chemistry and radiochemistry of As, Re and Rh isotopes relevant to radiopharmaceutical applications: high specific activity radionuclides for imaging and treatment.
Feng Y; Phelps TE; Carroll V; Gallazzi F; Sieckman G; Hoffman TJ; Barnes CL; Ketring AR; Hennkens HM; Jurisson SS
Dalton Trans; 2017 Oct; 46(42):14677-14690. PubMed ID: 28951905
[TBL] [Abstract][Full Text] [Related]
20. New method for production of
Moiseeva AN; Aliev RA; Furkina EB; Novikov VI; Unezhev VN
Nucl Med Biol; 2022; 106-107():52-61. PubMed ID: 35032789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
